Compare Nutanix Inc (NTNX) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Tempus AI — how do they compare? Nutanix Inc trades at $73.48 (market cap $19.78B), while Tempus AI trades at $70.4 (market cap $12.58B). The key difference: Nutanix Inc is the larger of the two by market cap, and Nutanix Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nutanix Inc for 17 Days and Tempus AI for 22 Days on average.
| NTNX | TEM | |
|---|---|---|
Market Cap | $19.78B | $12.58B |
Volume | 1,717,619 | 7,444,569 |
Sector | Technology | Broad Market / Factor |
52-Week High | $73.42 | $99.28 |
52-Week Low | $34.41 | $41.55 |
Typical Hold Time | 17 Days | 22 Days |
Enterprise Value | $18.94B | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutanix (NTNX) trades at $73.42, showing minimal daily movement with a 0.01% gain. The stock maintains a bullish technical outlook with strong moving average signals, though oscillators suggest some near-term caution. Fundamentally, the company demonstrates robust profitability with an 86.8% gross margin and has consistently beaten earnings expectations in recent quarters. Recent Gartner Magic Quadrant recognitions highlight competitive strength in server virtualization and hybrid infrastructure.
The investment outlook remains positive with 62.5% analyst buy ratings and a $76.11 consensus price target offering 3.7% upside. Key opportunities include external storage growth and AI initiatives, while risks involve supply chain pressures and competitive market dynamics. Revenue growth acceleration to $2.9B in 2026 with 52.8% net margins supports the bullish case.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
